15 completed, 5 unknown, 4 not yet recruiting, 2 recruiting. 29 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 29 | Completed 15, Unknown 5, Not yet recruiting 4, Recruiting 2, Active not recruiting 1, Terminated 1, Withdrawn 1 |
Follow Population Groups: new trials by email Literature Review of Population Groups trials Research Report on Population Groups
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy Comparison of 10-Day High-Dose Versus 14-Day Standard-Dose Vonoprazan Plus Amoxicillin in Helicobacter Pylori Eradication: A Multicenter Non-Inferiority Randomized Controlled Trial 10-day group, 14-day group - Helicobacter Infection, Vonoprazan | Phase 4 | Not yet recruiting | Shandong University | 232 | 2026-09-30 | 2026-09-29 |
| Efficacy and Safety of Anrikefon Injection for Multimodal Postoperative Analgesia in Patients Undergoing Laparoscopic Hepatectomy Anruikefon 1 μg/kg per dose Group, Anruikefon 100 μg per dose Group, Control group - Postoperative Acute Pain | Phase 4 | Not yet recruiting | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 117 | 2026-08-30 | 2026-09-03 |
| Comparison of the Analgesic Efficacy of Ultrasound-guided Retrolaminar Block Versus Serratus Anterior Plane Block in Patients Undergoing Radical Mastectomy Serratus Anterior Plane Block (SAPB) group, Retrolaminar block group - Serratus Anterior Plane Block | Phase 4 | Completed | Ain Shams University | 90 | 2026-05-17 | 2026-11-04 |
| Dose-escalation of Rectal Indomethacin for Preventing PEP standard-dose group VS high-dose group - Post-ERCP Pancreatitis | Phase 4 | Not yet recruiting | The First Affiliated Hospital of Anhui Medical University | 1036 | 2025-12-01 | 2025-11-25 |
| A Study Testing How Well the Drug Extract of Ginkgo Biloba Leaves Tablets Works for People With Memory or Thinking Problems After a Stroke When Added to Standard Treatment Extract of Ginkgo Biloba Leaves Tablets 240 mg (2 x 40 mg, t.i.d.), Standard of care (SoC) Group - Ischemic Stroke Hospitalized, Impairment, Cognitive | Phase 4 | Active not recruiting | Dr. Willmar Schwabe GmbH & Co. KG | 400 | 2025-11-28 | 2026-10-30 |
| Methadone to Reduce Chronic Opioid Use After Major Spine Surgery: The MEND Pilot Feasibility Study Methadone, Placebo - Post Operative Pain, Spinal Surgery | Phase 4 | Recruiting | The Cleveland Clinic | 120 | 2025-11-15 | 2025-12-17 |
| Effect of Henagliflozin on Renal Outcomes in Non-dialysis Patients With Advanced Chronic Kidney Disease : A Multicenter Prospective, Randomized Controlled Trial(HERO -aCKD) Henagliflozin 5 mg Group, Henagliflozin 10 mg Group, Conventional therapy group - Chronic Kidney Disease Stage 4 | Phase 4 | Not yet recruiting | First Affiliated Hospital of Wannan Medical College | 429 | 2025-07-10 | 2025-06-18 |
| Point-of-care Measurement of the Antifibrinolytic Activity of Tranexamic Acid in Cardiac Surgery Tranexamic acid bolus 20 mg/kg, Tranexamic acid bolus 10 mg/kg, Tranexamic acid bolus 1 mg/kg - Antifibrinolytic Agents | Phase 4 | Recruiting | Insel Gruppe AG, University Hospital Bern | 322 | 2023-12-15 | 2025-06-06 |
| Hemodynamic Response to Pain During Retinopathy Of Prematurity Screening benoxinate hydrochloride 0.4% group, saline 0.9% . - Preterm | Phase 4 | Completed | Alexandria University | 68 | 2023-01-20 | 2025-02-05 |
| Study on the Safety and Effectiveness of Remimazolam Tosilate for Injection for Short-term Elective Surgery in Adults Remimazolam Tosilate for Injection 0.1mg/kg, Remimazolam Tosilate for Injection 0.15mg/kg, Remimazolam Tosilate for Injection 0.2mg/kg - Hypotension During Surgery | Phase 4 | Completed | Tongji Hospital | 650 | 2021-07-01 | 2025-06-29 |
| Effects of 0.1% Nepafenac on Vitreous Inflammatory Biomarkers in Rhegmatogenous Retinal Detachment and Proliferative Vitreoretinopathy Nepafenac 0.1% eyedrops, Control (placebo) group - Proliferative Vitreoretinopathy, Rhegmatogenous Retinal Detachment | Phase 4 | Completed | Universitas Indonesia | 61 | 2021-04-28 | 2025-09-09 |
| The Potential Benefit of Xiao-Yao-San Treatment in Patients With Insomnia Xiao-Yao-San, Weight loss class(WLC) group - Treatment | Phase 4 | Completed | Yu-Ching HSU | 19 | 2019-01-01 | 2024-10-24 |
| Antibacterial-coated Sutures at Time of Cesarean Vicryl-plus, monocryl-plus, PDS-plus (Triclosan-coated Sutures), Vicryl, monocryl, PDS (not coated with triclosan) - Surgical Site Infection, Surgical Wound Infection | Phase 4 | Terminated | The University of Texas Medical Branch, Galveston | 1169 | 2018-01-09 | 2026-06-22 |
| Adequacy of Perioperative Cefazolin for Surgery Antibiotic Prophylaxis in Obese Patients Standard Dose Group, Weight Based Group - Obesity | Phase 4 | Withdrawn | University of Colorado, Denver | 2017-09-01 | 2017-12-06 | |
| Gabapentin as Preanesthetic Medication to Fast Procedures in Pediatric´s Oncology Placebo Group, GABA 15mg/kg Group, GABA 30mg/kg Group - Pain, Postoperative, Agitation States as Acute Reaction to Exceptional Stress | Phase 4 | Completed | Hospital Infantil Albert Sabin | 135 | 2017-07-01 | 2018-09-27 |
| Optimizing the Anticoagulation Regimen of Enoxaparin During Percutaneous Coronary Intervention (OPTIENOX-PCI) Enoxaparin (Staged-dose PCI Group), Enoxaparin (Single-dose PCI Group), Enoxaparin (High-dose Group) - Coronary Artery Disease, Percutaneous Coronary Intervention | Phase 4 | Completed | Peking Union Medical College Hospital | 378 | 2017-05-12 | 2022-10-12 |
| Effect of Hyperuricaemia on Chronic Renal Disease 20mg Febuxostat, 40mg Febuxostat - Hyperuricemia, Chronic Renal Disease | Phase 4 | Unknown | The Affiliated Hospital of Xuzhou Medical University | 400 | 2017-01-01 | 2018-02-07 |
| Effect of Rosuvastatin Therapy on HDL2 Level Rosuvastatin 10mg/d group, Rosuvastatin 20mg/d group - Hyperlipemia, Coronary Heart Disease | Phase 4 | Unknown | Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | 300 | 2015-11-01 | 2015-11-03 |
| Dose-dependent Effect of Rosuvastatin on Long-term Clinical Outcomes After PCI Rosuvastatin 5mg, Rosuvastatin 20mg - Coronary Artery Disease, Coronary Disease | Phase 4 | Unknown | Korea University Anam Hospital | 300 | 2015-09-01 | 2016-08-09 |
| P. Falciparum Resistance to Artemisinin in Vietnam Artesunate (AS) group, DHA - PPQ group - Drug Resistant Malaria Due to Plasmodium Falciparum | Phase 4 | Unknown | National Institute of Malariology, Parasitology and Entomology, Vietnam | 120 | 2015-04-01 | 2015-12-21 |
Showing 20 of 29. Sign in to see all of them.
Pain, Postoperative (4) · Coronary Artery Disease (3) · Coronary Disease (2) · Hyperlipidemias (2) · Renal Insufficiency, Chronic (2) · Atherosclerosis (1) · Cardiovascular Diseases (1) · Cognitive Dysfunction (1) · Depressive Disorder, Major (1) · Dyslipidemias (1) · Epilepsy (1) · Helicobacter Infections (1) · Hyperphagia (1) · Hyperuricemia (1) · Hypotension (1)
University of Colorado, Denver (2) · Ain Shams University (1) · Alexandria University (1) · Daewoong Pharmaceutical Co. LTD. (1) · Daping Hospital and the Research Institute of Surgery of the Third Military Medical University (1) · Dr. Willmar Schwabe GmbH & Co. KG (1) · Eisai Korea Inc. (1) · First Affiliated Hospital of Wannan Medical College (1) · Hospital Infantil Albert Sabin (1) · Insel Gruppe AG, University Hospital Bern (1) · Korea University Anam Hospital (1) · Kuopio University Hospital (1) · National Institute of Malariology, Parasitology and Entomology, Vietnam (1) · National Taiwan University Hospital (1) · Northwestern University (1)
China (7) · United States (5) · South Korea (3) · Egypt (2) · Taiwan (2) · Belgium (1) · Brazil (1) · Finland (1) · France (1) · Indonesia (1) · Switzerland (1) · Vietnam (1)
Ailin Luo, Doctor (1) · Andra Duncan, MD (1) · Anna Rosanas-Urgell, MD, PhD (1) · Annegret Kauert-Willms, MD (1) · Ari Djatikusumo, MD (1) · Benjamin Bush, M.D. (1) · Changzhen Shang (1) · Do-sun Lim, MD, PhD (1) · Dong Sun, MD (1) · Duong Tran, MD, PhD (1) · Herbert Meltzer, M.D. (1) · Hesham Ghazal, PhD (1) · Hyung Joon Joo, MD, PhD (1) · Jihee Mun (1) · Joon Pio Hong, MD (1)
PMID 11011804, PMID 11156876, PMID 11181470, PMID 11287711, PMID 12147872, PMID 12475453, PMID 12575964, PMID 12644342, PMID 12845386, PMID 14755805, PMID 15249498, PMID 15383472, PMID 1595522, PMID 16187968, PMID 16957147, PMID 17296821, PMID 17368152, PMID 17898099, PMID 18276619, PMID 18955731, PMID 19332455, PMID 19463333, PMID 20170785, PMID 20418301, PMID 20466199, PMID 21544927, PMID 21777368, PMID 21856483, PMID 22070834, PMID 22306479, PMID 22584085, PMID 22922414, PMID 23428644, PMID 23753843, PMID 23968700, PMID 24211309, PMID 24247671, PMID 24465490, PMID 24528685, PMID 24595147, PMID 24677734, PMID 24739590, PMID 24952056, PMID 25075159, PMID 25173339, PMID 25179260, PMID 25230144, PMID 25249586, PMID 25791214, PMID 25792206